NCT06662097View on ClinicalTrials.gov

A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
SurgeryNerve InjuryImaging
Interventions
DRUG

Bevonescein

Bevonescein is a sterile solution that is intravenously administered

Trial Locations (1)

92037

RECRUITING

University of California San Diego, San Diego

Sponsors
All Listed Sponsors
lead

Alume Biosciences, Inc.

INDUSTRY

NCT06662097 - A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery | Biotech Hunter | Biotech Hunter